Covid-19 Leaves Lasting Impact on Hematology at ASH 2020 Conference
Under the heavy shadow of the Covid-19 pandemic, last week’s annual conference of the American…
17/12/2020 - 6 minutes
Autolus
Autolus Reveals Early Clinical Data of Next-Gen CAR-T Therapy
London-based Autolus has shown its next-generation CAR T-cell therapy does not induce some of the…
09/12/2019 - 4 minutes
Manufacturing Delays Set Back Autolus’ CAR-T Programs by Five Months
The UK biotech Autolus’ shares have slumped as construction delays from a new manufacturing site…
12/08/2019 - 2 minutes
Next-Generation CAR-T Company Raises €130M on NASDAQ IPO
London-based Autolus has made its debut on the NASDAQ raising funds to boost the development of a…
22/06/2018 - 2 minutes
This British Biotech Could Treat T-Cell Lymphoma without Leaving the Body Unprotected
Autolus has revealed a new strategy to treat T-cell lymphoma without harming healthy, protective T…
14/11/2017 - 2 minutes
British Biotech Pockets Massive Series C for its CAR-T Cancer Therapies
Autolus, based in London, has raised €68M in Series C to continue developing its T cell…
26/09/2017 - 3 minutes
CAR-T Startup Gets €51M from Top&New Investors
Autolus (UK) has secured over €51M in a recent series B round, led by the…
21/03/2016 - 2 minutes
The Ultimate Review on how Biotech Changed Cancer Treatment
You have roughly 50% chance of developing a cancer in your life and 25% of…
20/10/2015 - 10 minutes
